Apple reportedly prototyped a compact Apple Pencil for its upcoming foldable iPhone but ultimately decided against including stylus support in the first-generation model.
The prototype was a shorter version of the Apple Pencil designed to magnetically attach to the side of the folding device, similar to how the Pencil connects to iPad.
Testing revealed a fundamental problem: when the stylus aligned with the tall edge of the closed phone, it blocked opening the device.
Users would need to remove it just to unfold the screen, even when they had no intention of drawing or writing.
Display concerns sealed the decision
Beyond the ergonomic awkwardness, Apple engineers reportedly worried about the display itself.
The concern was that the Apple Pencil could leave unsightly marks on the foldable screen, which by design is more delicate than a standard iPhone or iPad panel.
That combination of usability friction and potential display damage was apparently enough to shelve the idea for launch.
Customers should not expect any Apple Pencil compatibility when the iPhone Ultra ships, including with the USB-C version of the stylus.
Apple could revisit the idea in future hardware generations, but for now the product launches without it.
What this rules out for buyers
The absence of stylus support is a practical consideration for anyone hoping the iPhone Ultra could replace both their iPhone and iPad mini.
If you rely on the iPad mini as a drawing or note-taking tablet with Apple Pencil, that workflow does not transfer to the foldable iPhone.
Third-party capacitive styluses will still work with the device since they mimic the electrical signal produced by a fingertip.
Most are rubber-tipped or rechargeable, but they lack the precision of Apple Pencil and are not purpose-built for detailed illustration or handwriting.
September reveal approaching
Apple is expected to unveil the iPhone Ultra alongside the iPhone 18 Pro at its Surprise and Shine event on September 9. Pre-order timing and the exact release date have not yet been confirmed.